Joint replacement trials still tricky to compare

Just over half (55%) of all joint replacement trials report on pre-specified primary outcome measures and even when they do, there is a wide heterogeneity in the type of outcome measures, a review of literature reveals. The problem makes it difficult to compare findings between clinical trials and reliably answer important research questions. The systematic ...

Already a member?

Login to keep reading.

© 2021 the limbic